Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches - PubMed (original) (raw)
Review
Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches
C Behl. Prog Neurobiol. 1999 Feb.
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder with a deadly outcome. AD is the leading cause of senile dementia and although the pathogenesis of this disorder is not known, various hypotheses have been developed based on experimental data accumulated since the initial description of this disease by Alois Alzheimer about 90 years ago. Most approaches to explain the pathogenesis of AD focus on its two histopathological hallmarks, the amyloid beta protein- (A(beta)-) loaded senile plaques and the neurofibrillary tangles, which consist of the filament protein tau. Various lines of genetic evidence support a central role of A(beta) in the pathogenesis of AD and an increasing number of studies show that oxidation reactions occur in AD and that A(beta) may be one molecular link between oxidative stress and AD-associated neuronal cell death. A(beta) itself can be neurotoxic and can induce oxidative stress in cultivated neurons. A(beta) is, therefore, one player in the concert of oxidative reactions that challenge neurons besides inflammatory reactions which are also associated with the AD pathology. Consequently, antioxidant approaches for the prevention and therapy of AD are of central interest. Experimental as well as clinical data show that lipophilic antioxidants, such as vitamin E and estrogens, are neuroprotective and may help patients suffering from AD. While an additional intensive elucidation of the cellular and molecular events of neuronal cell death in AD will, ultimately, lead to novel drug targets, various antioxidants are already available for a further exploitation of their preventive and therapeutic potential. reserved
Similar articles
- [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection].
Behl C, Holsboer F. Behl C, et al. Fortschr Neurol Psychiatr. 1998 Mar;66(3):113-21. doi: 10.1055/s-2007-995246. Fortschr Neurol Psychiatr. 1998. PMID: 9565761 Review. German. - Vitamin E and other antioxidants in neuroprotection.
Behl C. Behl C. Int J Vitam Nutr Res. 1999 May;69(3):213-9. doi: 10.1024/0300-9831.69.3.213. Int J Vitam Nutr Res. 1999. PMID: 10389030 - Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models.
Gugliandolo A, Bramanti P, Mazzon E. Gugliandolo A, et al. Int J Mol Sci. 2017 Nov 23;18(12):2504. doi: 10.3390/ijms18122504. Int J Mol Sci. 2017. PMID: 29168797 Free PMC article. Review. - Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
Calabrese V, Butterfield DA, Stella AM. Calabrese V, et al. Ital J Biochem. 2003 Dec;52(4):177-81. Ital J Biochem. 2003. PMID: 15141484 Review. - Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach.
Behl C, Moosmann B. Behl C, et al. Free Radic Biol Med. 2002 Jul 15;33(2):182-91. doi: 10.1016/s0891-5849(02)00883-3. Free Radic Biol Med. 2002. PMID: 12106814 Review.
Cited by
- Mechanisms of MPP⁺-induced PC12 cell apoptosis via reactive oxygen species.
Zhu Q, Wang J, Zhang Y, Sun S. Zhu Q, et al. J Huazhong Univ Sci Technolog Med Sci. 2012 Dec;32(6):861-866. doi: 10.1007/s11596-012-1048-9. Epub 2012 Dec 28. J Huazhong Univ Sci Technolog Med Sci. 2012. PMID: 23271287 - Noncovalent interaction between amyloid-beta-peptide (1-40) and oleuropein studied by electrospray ionization mass spectrometry.
Bazoti FN, Bergquist J, Markides KE, Tsarbopoulos A. Bazoti FN, et al. J Am Soc Mass Spectrom. 2006 Apr;17(4):568-75. doi: 10.1016/j.jasms.2005.11.016. Epub 2006 Feb 28. J Am Soc Mass Spectrom. 2006. PMID: 16503156 - Protection of cholinergic and antioxidant system contributes to the effect of Vitamin D3 ameliorating memory dysfunction in sporadic dementia of Alzheimer's type.
Rodrigues MV, Gutierres JM, Carvalho F, Lopes TF, Antunes V, da Costa P, Pereira ME, Schetinger MRC, Morsch VM, de Andrade CM. Rodrigues MV, et al. Redox Rep. 2019 Dec;24(1):34-40. doi: 10.1080/13510002.2019.1617514. Redox Rep. 2019. PMID: 31100998 Free PMC article. - Cholesterol potentiates beta-amyloid-induced toxicity in human neuroblastoma cells: involvement of oxidative stress.
Ferrera P, Mercado-Gómez O, Silva-Aguilar M, Valverde M, Arias C. Ferrera P, et al. Neurochem Res. 2008 Aug;33(8):1509-17. doi: 10.1007/s11064-008-9623-y. Epub 2008 Feb 21. Neurochem Res. 2008. PMID: 18288607 - Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.
Trippier PC, Jansen Labby K, Hawker DD, Mataka JJ, Silverman RB. Trippier PC, et al. J Med Chem. 2013 Apr 25;56(8):3121-47. doi: 10.1021/jm3015926. Epub 2013 Mar 27. J Med Chem. 2013. PMID: 23458846 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical